Antithrombotic therapy is used after left atrial appendage occlusion (LAAO) to prevent device-related thrombosis (DRT) that could lead to stroke or transient ischemic attack (TIA). Ageing in atrial fibrillation (AF) as well as many age-associated comorbidities are known risk factor for stroke. Moreover, bleeding...
S. Mohanty, V. L. La Fazia, C. Gianni et al.· European Heart Journal· 0 citations
Prior studies have reported a significant association between early (ER) and late recurrence following catheter ablation for atrial fibrillation (AF). However, there is limited data on the factors contributing to ER post-pulsed field ablation (PFA). We aimed to assess the link between extended ablation and ER in...
S. Mohanty, V. L. La Fazia, C. Gianni et al.· European Heart Journal· 0 citations
BACKGROUND
The benefit of additional left atrial posterior wall ablation (LAPWA), beyond pulmonary vein isolation (PVI), in persistent atrial fibrillation (PersAF) treatment remains controversial.
OBJECTIVE
We investigated whether signals recorded with a pentaspline pulsed field ablation (PFA) catheter can identify P...
Lorenzo Bianchini, M. Schiavone, A. Gasperetti et al.· Heart Rhythm· 0 citations
BACKGROUND
The variable loop circular catheter has been shown to be a safe, effective pulsed field ablation catheter for atrial fibrillation treatment. After the commercial launch of the initial waveform (Seq1), a new waveform (Seq230 mL/min) was developed that reduces electrode surface temperature and ablation deliver...
L. di Biase, Jonathan C. Hsu, Rahul Bhardwaj et al.· Circulation: Arrhythmia and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.